Author

T. Uchikubo-Kamo

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Research Focus:transcription & RNA processing· 1

Frequent Co-Authors

M. Shirouzu· 2 shared C. Makino-Okamura· 1 shared C. T. Nguyen· 1 shared H. Fukuyama· 1 shared H. Ishigaki· 1 shared H. Saya· 1 shared H. Ueki· 1 shared K. Fukunaga· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

M. Shirouzu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivMar 31, 2023

Epigenetic mechanisms to propagate histone acetylation by p300/CBP

M. Kikuchi, S. Morita, M. Wakamori…·T. Umehara

This study identifies how p300/CBP reads and writes histone acetylation to propagate epigenetic marks and activate gene transcription.

DOI 10.1038/s41467-023-39735-4

ChIP-seqexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintJun 21, 2022

Fc-modified SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models.

M. Takeshita, H. Fukuyama, K. Kamada…·T. Takeuchi

The paper develops Fc-modified SARS-CoV-2 neutralizing antibodies effective against variants, showing reduced viral titers and lung damage in animal models.

DOI 10.1101/2022.06.21.496751

humanproteomics

𝕏 PostBluesky